Citation only via OpenAlex

Is Urolithin A(UA) a pharmacologically credible neuro-nutraceutical? A critical review of mechanisms, brain exposure, and evidence gaps in Alzheimer's and Parkinson's disease

Neurochemistry International · 2026

Chronic inflammation Review

Abstract

This 2026 review in Neurochemistry International examines Urolithin A as a potential neuro-nutraceutical. It evaluates brain exposure and evidence gaps.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: OpenAlex
DOI: 10.1016/j.neuint.2026.106224
Canonical: link ↗
Fetched: 2026-10-11 MST

Cite this

APA

Oswal, D.G., & Rane, M.M. (2026). Is Urolithin A(UA) a pharmacologically credible neuro-nutraceutical? A critical review of mechanisms, brain exposure, and evidence gaps in Alzheimer's and Parkinson's disease. <em>Neurochemistry International</em>. https://doi.org/10.1016/j.neuint.2026.106224

Vancouver

Oswal DG, Rane MM. Is Urolithin A(UA) a pharmacologically credible neuro-nutraceutical? A critical review of mechanisms, brain exposure, and evidence gaps in Alzheimer's and Parkinson's disease. Neurochemistry International. 2026. doi:10.1016/j.neuint.2026.106224.

BibTeX

@article{diya2026IsUrol, title = {Is Urolithin A(UA) a pharmacologically credible neuro-nutraceutical? A critical review of mechanisms, brain exposure, and evidence gaps in Alzheimer's and Parkinson's disease}, author = {Diya Girish Oswal and Meenal M. Rane}, journal = {Neurochemistry International}, year = {2026}, doi = {10.1016/j.neuint.2026.106224}, }